Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load

被引：0

作者：

Baijun Li

Zhaozhe Liu

Xing Liu

Dongchun Liu

Mingyu Duan

Ye Gu

Qiong Liu

Qiang Ma

Yushi Wei

Yan Wang

机构：

[1] The Sixth People’s Hospital of Shenyang,Cadre’s Ward

[2] General Hospital of Northern Theater Command,Oncology Department

[3] The Sixth People’s Hospital of Shenyang,Science and Education Department

[4] Shenyang Pharmaceutical University,School of Traditional Chinese Materia Medica

[5] Shenyang Beichuang Laboratory Co. Ltd,Clinical Chemistry Laboratory

[6] The Sixth People’s Hospital of Shenyang,Gastroenterology Departmentepartment

[7] Liaoning University of Traditional Chinese Medicine,undefined

来源：

Hepatology International | 2021年 / 15卷

关键词：

Tenofovir disoproxil fumarate; Tenofovir alafenamide fumarate; HBV vertical transmission; Pregnant women; Perinatal period; Drug safety;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1103 / 1108

页数：5

共 50 条

[31] COMPARATIVE EFFICACY AND RENAL SAFETY OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE FOR HBV-INFECTED CANCER PATIENTS UNDERGOING CHEMOTHERAPY
Lee, I-Cheng
Lan, Keng-Hsin
Su, Chien-Wei
Chao, Yee
Lin, Han-Chieh
Hou, Ming-Chih
Huang, Yi Hsiang
HEPATOLOGY, 2021, 74 : 473A - 474A
[32] Switching tenofovir disoproxil fumarate to tenofovir alafenamide not only bone and kidney
Berger, F.
Milinkovic, A.
Arenas-Pinto, A.
Mauss, S.
ANTIVIRAL THERAPY, 2018, 23 : A48 - A48
[33] Efficacy of tenofovir alafenamide- or tenofovir disoproxil fumarate-containing regimens in adults with HIV-HBV coinfection
Tabak, F.
Yildiz, D. S.
Zerdali, E.
Kurt, F.
Karaosmanoglu, H. Kumbasar
Koc, M. Meric
Gunduz, A.
Oncul, A.
Nakir, I. Yilmaz
Unlu, E. Canpolat
Aydin, O. Altuntas
Mete, B.
HIV MEDICINE, 2023, 24 : 645 - 646
[34] Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag, H.
Aladag, M.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (05) : 2091 - 2098
[35] Weight changes in patients with sustained viral suppression switching tenofovir disoproxil fumarate to tenofovir alafenamide
Schafer, Jason J.
Zimmerman, Matty
Walshe, Ciara
Cerankowski, Jesse
Shimada, Ayako
Keith, Scott W.
OBESITY, 2022, 30 (06) : 1197 - 1204
[36] Switching tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed adults
Orkin, C.
Clarke, A.
Gallant, J.
Daar, E.
Raffi, F.
Antonucci, S.
Mingjin, Y.
Chang, A.
Rhee, M.
HIV MEDICINE, 2016, 17 : 18 - 18
[37] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B
Lim, Jihye
Choi, Won-Mook
Shim, Ju Hyun
Lee, Danbi
Kim, Kang Mo
Lim, Young-Suk
Lee, Han Chu
Choi, Jonggi
LIVER INTERNATIONAL, 2022, 42 (07) : 1517 - 1527
[38] Efficacy and safety of switching therapy from tenofovir disoproxil fumarate to tenofovir alafenamide for hepatitis B virus infection
Kaneko, Shun
Kurosaki, Masayuki
Tamaki, Nobuharu
Itakura, Jun
Kirino, Sakura
Watakabe, Keiya
Osawa, Leona
Okada, Mao
Wan, Wang
Shimizu, Takao
Higuchi, Mayu
Takaura, Kenta
Yasui, Yutaka
Tsuchiya, Kaoru
Nakanishi, Hiroyuki
Takahashi, Yuka
Izumi, Namiki
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E469 - E469
[39] Which Form of Tenofovir Should Be Used Worldwide: Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide?
Hill, Andrew
CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 1006 - 1009
[40] Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis
Pan, Calvin Q.
Zhu, Lin
Yu, Andy S.
Zhao, Yuchan
Zhu, Bo
Dai, Erhei
CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 953 - 964

← 1 2 3 4 5 →